Suppr超能文献

从单一尿液样本中以内源性水平色谱分离多巴、二羟基苯乙酸、肾上腺素、去甲肾上腺素和多巴胺的快速方法。

Rapid procedure for chromatographic isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels.

作者信息

Dalmaz Y, Peyrin L

出版信息

J Chromatogr. 1978 Jan 1;145(1):11-27. doi: 10.1016/s0378-4347(00)81664-3.

Abstract

A three-step procedure has been investigated to extract 3,4-dihydroxyphenylalanine (DOPA), 3,4-dihydroxyphenylacetic acid (DOPAC), epinephrine (E), norepinephrine (NE) and dopamine (DA) from a single urinary sample with the object of obtaining extracts pure enough for specific fluorimetric assay. The procedure described in this paper results from the combination of urine purification on an aluminum oxide column, separation by ion-exchange chromatography of the DOPA-DOPAC fraction from catecholamines, and ether isolation of DOPAC from DOPA. The whole procedure is rapid and easily performed in one work day. Extraction recoveries were 72.4 +- 3.5%, 76 +- 2%, 85.7 +- 3.3%, 85.6 +- 1.4% and 92.4 +- 5.5% for DOPA, DOPAC, E, NE and DA respectively (n=6). The lowest amounts of the five catechols that could be detected in urinary samples by a combination of this extraction procedure and the methods of assay used in our laboratory were 15 ng for DOPA, 40 ng for NE, 20 ng for E, 152 ng for DA and 2.95 micrograms for DOPAC. Urinary volumes convenient for accurate estimation of each compound were 20 ml for healthy human subjects. For pathological or pharmacological purposes, 5 ml of human urine were sufficient. The daily excretion of DOPA, DOPAC, E, NE and DA found by this procedure agrees with data obtained by other authors in healthy subjects. In pathological samples, our three-step procedure led to lower amounts than methods using alumina purification only. The discrepancies between the two methods are discussed in terms of development of internal standards, relative specificity of fluorimetric assays, values of blank eluates, and the possibility of interference from unknown abnormal body metabolites or pharmacological drugs not eliminated by a single-step alumina purification.

摘要

为了从单个尿液样本中提取3,4 - 二羟基苯丙氨酸(DOPA)、3,4 - 二羟基苯乙酸(DOPAC)、肾上腺素(E)、去甲肾上腺素(NE)和多巴胺(DA),研究了一种三步提取程序,目的是获得纯度足以进行特定荧光测定的提取物。本文所述的程序是通过将尿液在氧化铝柱上进行纯化、通过离子交换色谱法从儿茶酚胺中分离DOPA - DOPAC馏分以及从DOPA中用乙醚分离DOPAC相结合而得到的。整个程序快速且易于在一个工作日内完成。DOPA、DOPAC、E、NE和DA的提取回收率分别为72.4±3.5%、76±2%、85.7±3.3%、85.6±1.4%和92.4±5.5%(n = 6)。通过这种提取程序与我们实验室使用的测定方法相结合,在尿液样本中能够检测到的五种儿茶酚的最低量分别为:DOPA为15 ng,NE为40 ng,E为20 ng,DA为152 ng,DOPAC为2.95微克。对于健康人类受试者,便于准确估计每种化合物的尿量为20 ml。对于病理或药理目的,5 ml人尿就足够了。通过该程序发现的DOPA、DOPAC、E、NE和DA的每日排泄量与其他作者在健康受试者中获得的数据一致。在病理样本中,我们的三步程序得到的量比仅使用氧化铝纯化的方法更低。从内标物的发展、荧光测定的相对特异性、空白洗脱液的值以及未通过单步氧化铝纯化消除的未知异常体内代谢物或药理药物产生干扰的可能性等方面讨论了两种方法之间的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验